Skip to main content
OpenTrials
Completed

NCT Number: NCT01075594

Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

The purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dyslipidemia Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Blagoevgrad, Bulgaria

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks
  • Signed Informed Consent

Exclusion criteria

  • Informed Consent not provided

Treatment and study plan

Primary outcomes

  1. The number and percentage of patients achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines

    Time frame: 6 months - one visit only, no follow-up visits

Secondary outcomes

  1. The number and percentage of subjects achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines for several subject subsets

    Time frame: 6 months - one visit only, no follow-up visits

  2. The number and percentage of subjects achieving LDL-C goals according to the NCEP ATP III / 2004 updated 2004 NCEP ATP III guidelines, overall and for several subject subsets

    Time frame: 6 months - one visit only, no follow-up visits

  3. The number and percentage of subjects achieving the non HDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III/national guidelines [<130mg/dL (3,37mmol/L)], in the following sub-population: patients with fasting triglycerides >200 mg/dL

    Time frame: 6 months - one visit only, no follow-up visits

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia

Acronym: CEPHEUS

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Feb 25, 2010
Registry last updated
Sep 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.